Influence of Age and Comorbidity on Colorectal Cancer Screening in the Elderly

American Journal of Preventive Medicine

Volumn 51, Issue 3, 2016, Pages e67-e75

  Klabunde, Carrie N ^a   Zheng, Yingye ^b   Quinn, Virginia P ^c   Beaber, Elisabeth F ^b   Rutter, Carolyn M ^d   Halm, Ethan A ^e   Chubak, Jessica ^f   Doubeni, Chyke A ^g   Haas, Jennifer S ^h   Kamineni, Aruna ^f   Schapira, Marilyn M ⁱ   Vacek, Pamela M ^j   Garcia, Michael P ^b   Corley, Douglas A ^k  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c KAISER PERMANENTE   (United States)

^d RAND CORPORATION   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f GROUP HEALTH RESEARCH INSTITUTE   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ UNIVERSITY OF PENNSYLVANIA   (United States)

^j UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^k DIVISION OF RESEARCH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AGED; ARTICLE; CANCER PATIENT; CANCER SCREENING; CHARLSON COMORBIDITY INDEX; CLINICAL PRACTICE; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL CANCER; COMORBIDITY; CONTROLLED STUDY; FECES ANALYSIS; FEMALE; FOLLOW UP; GROUPS BY AGE; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH STATUS; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; POPULATION RESEARCH; SIGMOIDOSCOPY; VERY ELDERLY; CALIFORNIA; COLORECTAL TUMOR; EARLY CANCER DIAGNOSIS; MASS SCREENING; PROCEDURES; STATISTICS AND NUMERICAL DATA; TRENDS;

AGE FACTORS; AGED; AGED, 80 AND OVER; CALIFORNIA; COHORT STUDIES; COLONOSCOPY; COLORECTAL NEOPLASMS; COMORBIDITY; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MASS SCREENING; OCCULT BLOOD;

EID: 84989837715     PISSN: 07493797     EISSN: 18732607     Source Type: Journal    
DOI: 10.1016/j.amepre.2016.04.018     Document Type: Article

References (41)

1. 1 U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 149:9 (2008), 627–637, 10.7326/0003-4819-149-9-200811040-00243.
2. 2 Levin, B., Lieberman, D.A., McFarland, B., et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the U.S. Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 134:5 (2008), 1570–1595, 10.1053/j.gastro.2008.02.002.
3. 3 Qaseem, A., Denberg, T.D., Hopkins, R.H., et al. Screening for colorectal cancer: a guidance statement from the American College of Physicians. Ann Intern Med 156:5 (2012), 378–386, 10.7326/0003-4819-156-5-201203060-00010.
4. 4 American Geriatrics Society Ethics Committee. Health screening decisions for older adults: AGS position paper. J Am Geriatr Soc 51:2 (2003), 270–271, 10.1046/j.1532-5415.2003.51069.x.
5. 5 Van Hees, F., Habbema, J.D., Meester, R.G., Lansdorp-Vogelaar, I., van Ballegooijen, M., Zauber, A.G., Should colorectal cancer screening be considered in the elderly persons without previous screening? A cost-effectiveness analysis. Ann Intern Med 160:11 (2014), 750–759, 10.7326/M13-2263.
6. 6 Cho, H., Klabunde, C.N., Yabroff, K.R., et al. Comorbidity-adjusted life expectancy: a new tool to inform recommendations for optimal screening strategies. Ann Intern Med 159:10 (2013), 667–677, 10.7326/0003-4819-159-10-201311190-00005.
7. 7 van Hees, F., Saini, S.D., Lansdorp-Vogelaar, I., et al. Personalizing colonoscopy screening for elderly individuals based on screening history, cancer risk, and comorbidity status could increase cost effectiveness. Gastroenterology 149:6 (2015), 1425–1437, 10.1053/j.gastro.2015.07.042.
8. 8 Ortman JM, Velkoff VA, Hogan H. An Aging Nation: The Older Population in the United States. Washington, DC: U.S. Census Bureau. www.census.gov/prod/2014pubs/p25-1140.pdf. Published May 2014. Accessed August 13, 2015.
9. 9 National Cancer Institute. SEER stat fact sheets: colon and rectum cancer. http://seer.cancer.gov/statfacts/html/colorect.html. Accessed August 13, 2015.
10. 10 Jiménez-Garcia, R., Hernandez-Barrera, V., Carrasco-Garrido, P., Gil, A., Prevalence and predictors of breast and cervical cancer screening among Spanish women with diabetes. Diabetes Care 32:8 (2009), 1470–1472, 10.2337/dc09-0479.
11. 11 Kiefe, C.I., Funkhouser, E., Fouad, M.N., May, D.S., Chronic disease as a barrier to breast and cervical cancer screening. J Gen Intern Med 13:6 (1998), 357–365, 10.1046/j.1525-1497.1998.00115.x.
12. 12 Mandelblatt, J.S., Gold, K., O'Malley, A.S., et al. Breast and cervix cancer screening among multiethnic women: role of age, health, and source of care. Prev Med 28:4 (1999), 418–425, 10.1006/pmed.1998.0446.
13. 13 Sewitch, M.J., Fournier, C., Dawes, M., et al. Do physician recommendations for colorectal cancer screening differ by patient age?. Can J Gastroenterol 21:7 (2007), 435–438, 10.1155/2007/938978.
14. 14 Walter, L.C., Fung, K.Z., Kirby, K.A., et al. Five-year downstream outcomes following prostate-specific antigen screening in older men. JAMA Intern Med 173:10 (2013), 866–873, 10.1001/jamainternmed.2013.323.
15. 15 Wee, C.C., McCarthy, E.P., Davis, R.B., Phillips, R.S., Obesity and breast cancer screening. J Gen Intern Med 19:4 (2004), 324–331, 10.1111/j.1525-1497.2004.30354.x.
16. 16 Deshpande, A.D., McQueen, A., Coups, E.J., Different effects of multiple health status indicators on breast and colorectal cancer screening in a nationally representative U.S. sample. Cancer Epidemiol 36:3 (2012), 270–275, 10.1016/j.canep.2011.10.001.
17. 17 Kim, S.C., Schneeweiss, S., Myers, J.A., Liu, J., Solomon, D.H., No differences in cancer screening rates in patients with rheumatoid arthritis compared to the general population. Arthritis Rheum 64:10 (2012), 3076–3082, 10.1002/art.34542.
18. 18 Singal, A.K., Lin, Y.L., Kuo, Y.F., Riall, T., Goodwin, J.S., Primary care physicians and disparities in colorectal cancer screening in the elderly. Health Serv Res 48:1 (2013), 95–113, 10.1111/j.1475-6773.2012.01433.x.
19. 19 Yasmeen, S., Xing, G., Morris, C., Chlebowski, R.T., Romano, P.S., Comorbidities and mammography use interact to explain racial/ethnic disparities in breast cancer stage at diagnosis. Cancer 117:14 (2011), 3252–3261, 10.1002/cncr.25857.
20. 20 IOM. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academies Press. https://iom.nationalacademies.org/Reports/2001/Crossing-the-Quality-Chasm-A-New-Health-System-for-the-21st-Century.aspx. Published 2001. Accessed August 13, 2015.
21. 21 Dinh, T.A., Alperin, P., Walter, L.C., Smith, R., Impact of comorbidity on colorectal cancer screening cost-effectiveness study in diabetic populations. J Gen Intern Med 27:6 (2012), 730–738, 10.1007/s11606-011-1972-6.
22. 22 Fisher, D.A., Judd, L., Sanford, N.S., Inappropriate colorectal cancer screening: findings and implications. Am J Gastroenterol 100:11 (2005), 2526–2530, 10.1111/j.1572-0241.2005.00322.x.
23. 23 Leach, C.R., Klabunde, C.N., Alfano, C.M., Smith, J.L., Rowland, J.H., Physician over-recommendation of mammography for terminally ill women. Cancer 118:1 (2012), 27–37, 10.1002/cncr.26233.
24. 24 Schonberg, M.A., McCarthy, E.P., Davis, R.B., Phillips, R.S., Hamel, M.B., Breast cancer screening in women aged 80 and older: results from a national survey. J Am Geriatr Soc 52:10 (2004), 1688–1695, 10.1111/j.1532-5415.2004.52462.x.
25. 25 Walter, L.C., Bertenthal, D., Lindquist, K., Konety, B.R., PSA screening among elderly men with limited life expectancies. JAMA 296:19 (2006), 2336–2342, 10.1001/jama.296.19.2336.
26. 26 Garman, K.S., Jeffreys, A., Coffman, C., Fisher, D.A., Colorectal cancer screening, comorbidity, and follow-up in elderly patients. Am J Med Sci 332:4 (2006), 159–163, 10.1097/00000441-200610000-00001.
27. 27 Tiro, J.A., Kamineni, A., Levin, T.R., et al. The colorectal cancer screening process in community settings: a conceptual model for the Population-Based Research Optimizing Screening through Personalized Regimens Consortium. Cancer Epidemiol Biomarkers Prev 23:7 (2014), 1–12, 10.1158/1055-9965.EPI-13-1217.
28. 28 Charlson, M.E., Pompei, P., Ales, K.L., MacKenzie, C.R., A new method of classifying comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:5 (1987), 373–383, 10.1016/0021-9681(87)90171-8.
29. 29 Quan, H., Sundararajan, V., Halfon, P., et al. Coding algorithms for defining comorbidity in ICD-9-CM and ICD-10 administrative data. Med Care 43:11 (2005), 1130–1139, 10.1097/01.mlr.0000182534.19832.83.
30. 30 Tosteson, A.N., Beaber, E.F., Tiro, J., et al. Variation in screening abnormality rates and follow-up of breast, cervical and colorectal cancer screening within the PROSPR consortium. J Gen Intern Med 31 (2016), 372–379, 10.1007/s11606-015-3552-7.
31. 31 Korn, E., Graubard, B., Analysis of Health Surveys. 1999, Wiley, New York, NY, 10.1002/9781118032619.
32. 32 Graubard, B.I., Korn, E.L., Predictive margins with survey data. Biometrics 55:2 (1999), 652–659, 10.1111/j.0006-341X.1999.00652.x.
33. 33 Saini, S.D., van Hees, F., Vijan, S., Smarter screening for cancer: possibilities and challenges of personalization. JAMA 312:21 (2014), 2211–2212, 10.1001/jama.2014.13933.
34. 34 Lansdorp-Vogelaar, I., Gulati, R., Mariotto, A.B., et al. Personalizing age of cancer screening cessation based on comorbid conditions. Ann Intern Med 161:2 (2014), 104–112, 10.7326/M13-2867.
35. 35 Wolfson, M.C., Health-adjusted life expectancy. Health Rep 8:1 (1996), 41–46.
36. 36 Yabroff, K.R., Zapka, J., Klabunde, C.N., et al. Systems strategies to support cancer screening in U.S. primary care practice. Cancer Epidemiol Biomarkers Prev 20:12 (2011), 2471–2479, 10.1158/1055-9965.EPI-11-0783.
37. 37 Chubak, J., Garcia, M.P., Burnett-Hartman, A., et al. Time to colonoscopy after positive fecal blood test in four U.S. health care systems. Cancer Epidemiol Biomarkers Prev 25:2 (2016), 344–350, 10.1158/1055-9965.EPI-15-0470.
38. 38 Shapiro, J.A., Klabunde, C.N., Thompson, T.D., Nadel, M.R., Seeff, L.C., White, A., Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 21:6 (2012), 895–904, 10.1158/1055-9965.EPI-12-0192.
39. 39 Mariotto, A.B., Yabroff, K.R., Shao, Y., Feuer, E.J., Brown, M.L., Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst 103:2 (2011), 117–128, 10.1093/jnci/djq495.
40. 40 Klabunde, C.N., Shapiro, J.A., Kobrin, S., Nadel, M.R., Zapka, J.M., Colorectal cancer screening in U.S. seniors ages 76-84 years. J Community Health 40:4 (2015), 769–779, 10.1007/s10900-015-9998-z.
41. 41 Benning, T.M., Dellaert, B.G., Severens, J.L., Dirksen, C.D., The effect of presenting information about invasive follow-up testing on individuals’ noninvasive colorectal cancer screening participation decisions: results from a discrete choice experiment. Value Health 17:5 (2014), 578–587, 10.1016/j.jval.2014.04.007.